advertisement

---

Raber S 2

Showing records 1 to 2 | Display all abstracts from Raber S

46688 A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension
Schachar RA; Raber S; Courtney R; Zhang M
Current Eye Research 2011; 36: 809-817

---

46655 Latanoprost Systemic Exposure in Pediatric and Adult Patients with Glaucoma: A Phase 1, Open-Label Study
Raber S; Courtney R; Maeda-Chubachi T; Simons BD; Freedman SF; Wirostko B
Ophthalmology 2011;

---